The Pheochromocytoma Market was valued at USD 0.5 billion in 2024 and is projected to reach USD 1.2 billion by 2034, registering a CAGR of 8.5%. This growth trajectory is underpinned by several critical factors, including rising awareness of the disease, advancements in diagnostic technologies, and an increase in healthcare expenditure. The growing prevalence of pheochromocytoma, a rare tumor...